MXPA03009583A - Ftalazinonas novedosas. - Google Patents
Ftalazinonas novedosas.Info
- Publication number
- MXPA03009583A MXPA03009583A MXPA03009583A MXPA03009583A MXPA03009583A MX PA03009583 A MXPA03009583 A MX PA03009583A MX PA03009583 A MXPA03009583 A MX PA03009583A MX PA03009583 A MXPA03009583 A MX PA03009583A MX PA03009583 A MXPA03009583 A MX PA03009583A
- Authority
- MX
- Mexico
- Prior art keywords
- phthalazinones
- novel
- novel phthalazinones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Psychology (AREA)
- AIDS & HIV (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01110228 | 2001-04-25 | ||
| PCT/EP2002/004438 WO2002085906A2 (en) | 2001-04-25 | 2002-04-23 | Phthalazinones derivatives useful as pde4/7 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03009583A true MXPA03009583A (es) | 2004-02-12 |
Family
ID=8177249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03009583A MXPA03009583A (es) | 2001-04-25 | 2002-04-23 | Ftalazinonas novedosas. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7186710B2 (es) |
| EP (1) | EP1385848A2 (es) |
| JP (1) | JP2004526789A (es) |
| KR (1) | KR20040008162A (es) |
| CN (1) | CN1503792A (es) |
| AU (1) | AU2002317733B2 (es) |
| BG (1) | BG108294A (es) |
| BR (1) | BR0209149A (es) |
| CA (1) | CA2445233A1 (es) |
| CZ (1) | CZ299347B6 (es) |
| EA (1) | EA200301100A1 (es) |
| EE (1) | EE200300514A (es) |
| HR (1) | HRP20030868A2 (es) |
| HU (1) | HUP0303998A3 (es) |
| IL (1) | IL157908A0 (es) |
| MX (1) | MXPA03009583A (es) |
| NO (1) | NO20034773L (es) |
| NZ (1) | NZ529221A (es) |
| PL (1) | PL363312A1 (es) |
| SK (1) | SK14342003A3 (es) |
| WO (1) | WO2002085906A2 (es) |
| ZA (1) | ZA200308930B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953853B2 (en) | 2001-02-15 | 2005-10-11 | Altana Pharma Ag | Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| US7022696B2 (en) * | 2001-04-25 | 2006-04-04 | Altana Pharma Ag | Piperazino-derivatives and their use as PDE4 inhibitor |
| ATE360627T1 (de) * | 2002-08-10 | 2007-05-15 | Altana Pharma Ag | Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren |
| PL373597A1 (en) * | 2002-08-10 | 2005-09-05 | Altana Pharma Ag | Piperidine-n-oxide-derivatives |
| AU2003255376A1 (en) * | 2002-08-10 | 2004-03-11 | Altana Pharma Ag | Piperidine-derivatives as pde4 inhibitors |
| EP1556369A1 (en) * | 2002-08-10 | 2005-07-27 | ALTANA Pharma AG | Pyridazinone-derivatives as pde4 inhibitors |
| ES2304692T3 (es) | 2004-02-04 | 2008-10-16 | Nycomed Gmbh | Derivados de 2-(piperidin-4-il)-4,5-dihidro-2h-piridazin-3-ona como inhibidores de pde4. |
| WO2005075437A1 (en) * | 2004-02-04 | 2005-08-18 | Altana Pharma Ag | Pyridazinone derivatives and their use as pde4 inhibitors |
| KR20070042164A (ko) * | 2004-07-05 | 2007-04-20 | 아스텔라스세이야쿠 가부시키가이샤 | 피라졸로피리딘 유도체 |
| AU2006240730A1 (en) * | 2005-04-21 | 2006-11-02 | Nippon Shinyaku Co., Ltd. | Phthalazinone derivative and pharmaceutical comprising the same |
| ES2308916B1 (es) | 2007-03-22 | 2009-10-29 | Consejo Superior De Investigaciones Cientificas | Compuesto inhibidor dual de las enzimas pde7 y/o pde4, composiciones farmaceuticas y sus aplicaciones. |
| US8637528B2 (en) | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
| MX2009010450A (es) | 2007-03-27 | 2009-11-23 | Omeros Corp | El uso de inhibidores de la fosfodiesterasa 7 para el tratamiento transtornos del movimiento. |
| SI2148876T1 (sl) | 2007-05-16 | 2012-01-31 | Nycomed Gmbh | Pirazolonski derivati kot PDE4 inhibitorji |
| AR074318A1 (es) | 2008-11-14 | 2011-01-05 | Nycomed Gmbh | Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias. |
| SG171765A1 (en) | 2008-11-20 | 2011-07-28 | Genentech Inc | Pyrazolopyridine pi3k inhibitor compounds and methods of use |
| JP2014504271A (ja) | 2010-11-08 | 2014-02-20 | オメロス コーポレーション | Pde7インヒビターを用いる嗜癖および衝動制御障害の処置 |
| US9220715B2 (en) | 2010-11-08 | 2015-12-29 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
| US9504663B2 (en) | 2011-02-07 | 2016-11-29 | Scipharm Sarl | Composition for the treatment of cystic fibrosis |
| AR086915A1 (es) * | 2011-06-17 | 2014-01-29 | Nycomed Gmbh | Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| CN102964340B (zh) * | 2012-12-12 | 2015-10-07 | 中国药科大学 | 一类治疗阿尔茨海默病的选择性多巴胺d1受体激动剂 |
| AU2014243818B2 (en) | 2013-03-13 | 2017-04-20 | Flatley Discovery Lab, Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
| CN112876460B (zh) * | 2021-02-05 | 2022-05-31 | 山西大学 | 7-二乙胺基-3-乙酰基香豆素衍生物及其合成方法和应用 |
| CN119894518A (zh) | 2022-08-18 | 2025-04-25 | 米托迪治愈有限责任公司 | 取代的苯并噁唑和苯并呋喃化合物用于治疗和预防与慢性疲劳、筋疲力尽和/或劳累不耐受相关的疾病的用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5716954A (en) | 1991-10-09 | 1998-02-10 | Syntex U.S.A. Inc. | Benzopyridazinone and pyridopyridazinone compounds |
| KR100263494B1 (ko) | 1991-10-09 | 2000-08-01 | 헤르빅 폰 모르체 | 피리도피리다지논 및 피리다진티온 화합물 |
| AU673569B2 (en) | 1992-12-02 | 1996-11-14 | Pfizer Inc. | Catechol diethers as selective PDE-IV inhibitors |
| DE19533975A1 (de) | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
| HUP0001541A3 (en) * | 1997-01-15 | 2001-11-28 | Altana Pharma Ag | Phthalazinone derivatives and pharmaceutical compositions containing them |
| DE69821530T2 (de) | 1997-12-15 | 2004-12-23 | Altana Pharma Ag | Dihydrobenzifurane |
| WO1999031071A1 (en) | 1997-12-15 | 1999-06-24 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New phthalazinones |
| EP0934933A1 (en) | 1998-02-06 | 1999-08-11 | Byk Gulden Lomberg Chemische Fabrik GmbH | Phthalazinones |
| JP2002506856A (ja) | 1998-03-14 | 2002-03-05 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | フタラジノンpdeiii/iv阻害剤 |
| WO2001019818A1 (en) | 1999-09-14 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinone derivatives as pd3/4 inhibitors |
| HK1047276A1 (zh) | 1999-10-25 | 2003-02-14 | Altana Pharma Ag | 作为pde4抑制剂的四氢噻喃2,3-二氮杂萘酮类衍生物 |
| DE60036558D1 (de) * | 1999-10-25 | 2007-11-08 | Nycomed Gmbh | Phthalazinon-derivate als pde 4 hemmer |
| KR20030031907A (ko) | 2000-06-05 | 2003-04-23 | 알타나 파마 아게 | β-2-아드레날린 수용체 작동물질로서 뿐만 아니라PDE4-억제제로서 효과적인 화합물 |
-
2002
- 2002-04-23 JP JP2002583433A patent/JP2004526789A/ja not_active Withdrawn
- 2002-04-23 KR KR10-2003-7013937A patent/KR20040008162A/ko not_active Withdrawn
- 2002-04-23 WO PCT/EP2002/004438 patent/WO2002085906A2/en not_active Ceased
- 2002-04-23 AU AU2002317733A patent/AU2002317733B2/en not_active Ceased
- 2002-04-23 HR HR20030868A patent/HRP20030868A2/xx not_active Application Discontinuation
- 2002-04-23 PL PL02363312A patent/PL363312A1/xx not_active Application Discontinuation
- 2002-04-23 IL IL15790802A patent/IL157908A0/xx unknown
- 2002-04-23 HU HU0303998A patent/HUP0303998A3/hu unknown
- 2002-04-23 EP EP02747291A patent/EP1385848A2/en not_active Withdrawn
- 2002-04-23 US US10/475,657 patent/US7186710B2/en not_active Expired - Fee Related
- 2002-04-23 BR BR0209149-6A patent/BR0209149A/pt not_active Application Discontinuation
- 2002-04-23 CN CNA028087429A patent/CN1503792A/zh active Pending
- 2002-04-23 CA CA002445233A patent/CA2445233A1/en not_active Abandoned
- 2002-04-23 MX MXPA03009583A patent/MXPA03009583A/es unknown
- 2002-04-23 SK SK1434-2003A patent/SK14342003A3/sk not_active Application Discontinuation
- 2002-04-23 EA EA200301100A patent/EA200301100A1/ru unknown
- 2002-04-23 NZ NZ529221A patent/NZ529221A/en unknown
- 2002-04-23 EE EEP200300514A patent/EE200300514A/xx unknown
- 2002-04-23 CZ CZ20033206A patent/CZ299347B6/cs not_active IP Right Cessation
-
2003
- 2003-10-24 NO NO20034773A patent/NO20034773L/no not_active Application Discontinuation
- 2003-10-27 BG BG108294A patent/BG108294A/bg unknown
- 2003-11-17 ZA ZA200308930A patent/ZA200308930B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ529221A (en) | 2005-04-29 |
| ZA200308930B (en) | 2004-06-09 |
| EP1385848A2 (en) | 2004-02-04 |
| AU2002317733B2 (en) | 2007-12-13 |
| SK14342003A3 (sk) | 2004-05-04 |
| IL157908A0 (en) | 2004-03-28 |
| BR0209149A (pt) | 2004-07-13 |
| CZ299347B6 (cs) | 2008-06-25 |
| BG108294A (bg) | 2004-09-30 |
| JP2004526789A (ja) | 2004-09-02 |
| CA2445233A1 (en) | 2002-10-31 |
| WO2002085906A2 (en) | 2002-10-31 |
| US20040127707A1 (en) | 2004-07-01 |
| NO20034773L (no) | 2003-12-10 |
| CZ20033206A3 (cs) | 2004-02-18 |
| NO20034773D0 (no) | 2003-10-24 |
| KR20040008162A (ko) | 2004-01-28 |
| US7186710B2 (en) | 2007-03-06 |
| EA200301100A1 (ru) | 2004-06-24 |
| CN1503792A (zh) | 2004-06-09 |
| WO2002085906A3 (en) | 2002-12-19 |
| HUP0303998A3 (en) | 2007-03-28 |
| HUP0303998A2 (hu) | 2004-05-28 |
| HRP20030868A2 (en) | 2005-08-31 |
| EE200300514A (et) | 2004-02-16 |
| PL363312A1 (en) | 2004-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200208561B (en) | Hydraulischer druckverstarker. | |
| MXPA03009583A (es) | Ftalazinonas novedosas. | |
| MXPA03009558A (es) | Compuestos novedosos. | |
| MXPA03009229A (es) | Microcapsulas. | |
| MXPA03005081A (es) | Elevador. | |
| MXPA01009037A (es) | I-bet. | |
| MXPA03007915A (es) | Vacuna. | |
| MXPA03005286A (es) | METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA. | |
| MXPA02002950A (es) | Dispositivo para surtir bolsa de plastico. | |
| MXPA03008139A (es) | Fluoralcoxifenilsulfonilureas sustituidas. | |
| MXPA03009073A (es) | Altavoz. | |
| MXPA03008394A (es) | Derivados de biuretano. | |
| MXPA03004242A (es) | Nuevas fenilpiperazinas. | |
| MXPA03007888A (es) | Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos. | |
| ZA200200597B (en) | Combination theraphy. | |
| GB0221380D0 (en) | P.D.P conquest | |
| ZA200204985B (en) | Activated rec-D-hydantoinases. | |
| ZA200205516B (en) | Process. | |
| AP2001000098S (en) | Marimbira. | |
| MXPA01005709A (es) | Panel-cimbra. | |
| MXPA01005710A (es) | Losa-cimbra. | |
| GB0128860D0 (en) | O.t.d | |
| GB0118494D0 (en) | P.c.o. | |
| GB0116210D0 (en) | P.c.o | |
| ZA200203782B (en) | Apension scheme. |